AVITA Medical, Inc.
RCEL
$9.91
-$0.15-1.49%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -43.08M | -45.34M | -48.59M | -48.56M | -51.57M |
| Total Depreciation and Amortization | 2.45M | 2.40M | 2.29M | 2.06M | 1.79M |
| Total Amortization of Deferred Charges | 53.00K | 53.00K | 53.00K | -- | -- |
| Total Other Non-Cash Items | 12.40M | 10.96M | 11.61M | 14.00M | 13.88M |
| Change in Net Operating Assets | 3.96M | 967.00K | 3.44M | -1.34M | 70.00K |
| Cash from Operations | -24.23M | -30.96M | -31.20M | -33.84M | -35.83M |
| Capital Expenditure | -387.00K | -803.00K | -1.01M | -3.29M | -6.12M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 987.00K | 4.53M | 13.46M | 18.20M | 33.76M |
| Cash from Investing | 600.00K | 3.73M | 12.45M | 14.91M | 27.65M |
| Total Debt Issued | 49.08M | 49.08M | -- | -- | -- |
| Total Debt Repaid | -42.98M | -42.98M | -- | -- | -- |
| Issuance of Common Stock | 15.51M | 15.63M | 15.99M | 16.77M | 2.95M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.06M | -1.06M | -1.06M | -1.06M | -- |
| Cash from Financing | 20.55M | 20.67M | 14.94M | 15.71M | 2.95M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.08M | -6.56M | -3.81M | -3.22M | -5.24M |